Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
about
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionTargeting interleukin-1 in heart diseaseCholesterol crystals and inflammationMolecular and cellular aspects of calcific aortic valve diseaseRegulation of Nlrp3 inflammasome by dietary metabolitesInflammasomes and metabolic disorders: old genes in modern diseasesVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms.Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in miceRole of smooth muscle cells in the initiation and early progression of atherosclerosis.Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Molecular evidence for arterial repair in atherosclerosisThe interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Inflammasomes in cardiovascular diseases.Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis.Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.Atherosclerosis and innate immune signaling.Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.Roles of heat-shock protein 70 in protecting against intestinal mucosal damageCytokines and atherosclerosis: a comprehensive review of studies in miceThe Expression of CD14(+)CD16(+) Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis SyndromeClosing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feedingAnalysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion.Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in miceOverexpression of NF-κB p65 in macrophages ameliorates atherosclerosis in apoE-knockout miceThe role of IL-1 in the pathogenesis of heart disease.Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.Interleukin-1 antagonists for diabetes.Targeting inflammation: impact on atherothrombosis.The role of the inflammasome in cardiovascular diseases.Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes.Atherosclerosis and aortic aneurysm - is inflammation a common denominator?Immune-mediated mechanisms of atherosclerosis and implications for the clinic.
P2860
Q26770209-ADE3728D-1178-411E-9B0D-7BCE01FB3C32Q27009347-6DC2AEAD-ADD8-4BAC-9C44-46F826E3ACDEQ27024737-0B220068-EF56-44DD-A945-225A3528F303Q27026105-5E727ED6-984E-4DE5-954A-E7C0BF269A16Q28078340-3DCB2C4D-7A59-487E-98A7-6E81C006CB6FQ28389531-C40EE030-F252-422A-8DDA-CE3CE7ACB513Q30319434-BD3616AC-BB50-4066-BCCE-ECBC6DDFB12EQ30421700-F8B51FD8-F232-4AF1-91A0-480B4967A31EQ30429015-B4639600-6E05-43C2-9526-5FAD14431887Q30438867-17064822-BFC2-4CB0-B44C-DB00E624944FQ33561072-46043B33-CC70-43BB-AA3F-53BB5662830AQ34120522-F1B58549-1EFD-4FF4-8344-784039D55792Q34769627-58EA2FCB-FFCB-4A4A-80BF-52B640F86D33Q35006409-F634FF7C-D867-4D54-B3E9-225CD4D5AFD8Q35539166-AE1F7905-591B-471D-806E-185A92926C1AQ35640438-6812D835-AB23-462C-94F1-7A50AF87343BQ35660178-56131C2B-8E3D-47B3-AD5E-5B51078FB70BQ35952305-E9F399CE-5D6F-47BC-BDF8-7EBEEE84B08DQ36099980-4BB0876D-C99D-4077-915D-630D91FE4A0CQ36198508-4943BCE8-C82E-4B1B-AEB1-F11275385456Q36344968-40714669-E4A5-4EC4-B021-0684A3E25084Q36664121-87E29AD9-6ADC-4B54-847B-73D8C8720DA8Q36802942-D3705B4B-A3FC-438E-85D3-B73163E71222Q37015512-4209E627-EE30-4F5A-BAFE-431A59BE5905Q37026106-0A854E47-8A8C-44D1-9D1D-54D65285408BQ37077297-D636B576-2377-4424-9E37-842A9A4E5712Q37141472-988C983B-0E0C-4BCF-AC26-4D21301FD36BQ37148996-3887B732-8522-4007-87FF-5DE6BD930CCEQ37338935-4ED7A848-6154-4C86-AB30-8A3E9C23472EQ37350730-DDADAE66-1E5C-4715-89AC-5B4F21053A10Q37439775-9FAC49C6-26C4-4476-B006-19EBF3420E51Q37460270-85ED37F2-0E2D-43D7-AFE1-C4A1669704F7Q37810915-0955DD07-CF28-476B-9D6F-02D693FDC0AFQ38008700-D287D8F6-E3F4-4C9E-9AB6-8CE7C0163A4BQ38109212-4ABF31BC-98CB-406A-8322-EB9EF856043EQ38170328-0389DD2C-6069-47AB-95BA-26A725C26762Q38196722-E51C4A31-D2A5-47C3-9FA5-E2F37311A018Q38369098-FE55F1F9-93F9-425E-A564-4E3B7AD386CBQ38678102-74BCAF99-C9E3-497B-B278-C830D5D9B2BFQ38851472-3A29B3AF-42FE-4C9A-B897-4CAF04E1D00E
P2860
Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@en
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@nl
type
label
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@en
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@nl
prefLabel
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@en
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@nl
P2093
P1476
Lack of interleukin-1 receptor ...... olipoprotein E-deficient mice.
@en
P2093
Fumitaka Ohsuzu
Kikuo Isoda
Koji Miyazaki
Masatoshi Kusuhara
Norio Ishigami
Shojiro Sawada
Taizo Matsuki
P304
P356
10.1161/01.ATV.0000127025.48140.A3
P407
P577
2004-04-01T00:00:00Z